Addressing Climate Change

Biotechnology is bringing us climate-smart technologies to recycle carbon, reduce greenhouse gas emissions and strengthen the resilience of agriculture and food production. Explore the resources and news updates on this page to learn BIO’s work for policy that allows biotech to reach its full potential as climate-tech.

Explore BIO's Impact at COP

Discover how BIO is shaping the future at the Conference of the Parties (COP). Uncover our commitment to sustainability, innovation, and global collaboration in the biotech industry. Join us in navigating the intersection of science, policy, and environmental stewardship at COP.

Bold Goals for Biotechnology: Promoting continued innovation and progress in the bioeconomy

BIO wholeheartedly supports the Biden administration’s Executive Order and its related “Bold Goals for U.S. Biotechnology and Biomanufacturing.” We urge action to operationalize those goals.

BIO Resources
Scanning plants

BIO’s Climate Report

Examining biotechnology's contributions to addressing the climate crisis.

Climate Policy Innovation Series: Food & Ag Systems

Climate Policy Innovation Series: Food & Ag Systems

Discover policies backing agri-innovation for eco-friendly farming and secure food supply.

Biotech Crops Are Driving Global Solutions to Climate Change

Climate Policy Innovation Series: Fueling the Energy Transition

Discover effective regulations to drive innovation across tech stages: research, development, demo, and deployment.

BIO Advocate Toolkit

Top BIO News Stories on Climate

Read the latest Climate Change blogposts on

Earth Day


ICBA partners with its national authorities and international organizations to overcome global challenges.

small plants

BIO supports the Growing Climate Solutions Act (GCSA) (S. 1251/H.R. 2820), which will foster sustainability and economic resiliency in agriculture and preserve America’s rich environmental diversity.


Industrial plant

In recent years, America’s position as the global leader in new technologies has come under attack. As countries race to secure access to these technologies, governments are working to weaken global rules and international organizations, instead of investing in innovation.

Letters, Comments & Testimony
April 11, 2024
We, the undersigned, are writing to express our strong concern with a proposed update to the Medicaid Drug Rebate Program. If finalized in its current form, the proposed rule (CMS-2434-P) would impose significant costs to the government and industry and create extensive barriers to patient access…
April 1, 2024
In response to the 340B Request for Information issued by the Senate 340B Bipartisan Working Group, BIO submits detailed comments.
January 22, 2024
The Biotechnology Innovation Organization (BIO) appreciates the opportunity to comment on the U.S. Senate Committee on Health, Education, Labor, and Pensions’ (Committee’s) Request for Information on Improving and Protecting Access to Gene Therapies (the RFI).